1. (1992). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41(RR-17), 1–19.
2. (2002). Cancer incidence in five continents. Volume VIII. IARC Sci Publ 155, 1–781.
3. (2007). Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence – SEER 9 Regs Limited-Use, Nov 2006 Sub (1973–2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch.
4. Ambrosino, C., Ruocco, M. R., et al. (1997). HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors. J Biol Chem 272(23), 14883–14892.
5. Aoki, Y., and Tosato, G. (2004). HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity. Blood 104(3), 810–814.